Actuate Therapeutics Announces Poster Presentations at the 2023 AACR Annual Meeting
CHICAGO and FORT WORTH, Texas, April 10, 2023 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (Actuate),…
News
Actuate Therapeutics Announces Poster Presentations at the 2023 AACR Annual Meeting
CHICAGO and FORT WORTH, Texas, April 10, 2023 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (Actuate),…
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (omadacycline) and Investigator-Initiated Research Programs at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (omadacycline) and Investigator-Initiated Research Programs at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Abeona Therapeutics Announces Multiple Abstracts Accepted from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
CLEVELAND, April 10, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the…
Abeona Therapeutics Announces Multiple Abstracts Accepted from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
CLEVELAND, April 10, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the…
ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310
TORONTO, Ontario and CAMBRIDGE, Massachusetts, April 10, 2023 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (TSX:…
ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310
TORONTO, Ontario and CAMBRIDGE, Massachusetts, April 10, 2023 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (TSX:…
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
STAMFORD, Conn., April 10, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical…
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
STAMFORD, Conn., April 10, 2023 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical…
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
Barbara Klencke, M.D. Dr. Klencke is an accomplished oncology drug developer with a demonstrated track…
Verizon continues to upgrade St. Louis’ best network
Recent upgrades lead to testing results that show Verizon customers have the best network experience…
DT Research to Unveil Medical Graphics Stations Purpose-built for Augmented Reality Navigation, Robotic Surgeries and 3D Simulations at HIMSS
All-in-one computers powered by NVidia® graphics cards and Intel® high-performance processors designed to provide real-time…
FloQast Introduces Custom Value Assessment Report for Improved Efficiency Across Financial Close Processes
Custom value assessment calculator quantifies accounting transparency and agility for teams seeking optimization and modernization…
FourKites and Pegasus Logistics Group Partner to Provide End-to-End Multimodal Visibility to Customers Worldwide
Adoption of FourKites’ leading supply chain visibility platform signals Pegasus Logistics’ long-term commitment to digitization…
Orezone Intersects 30.86 g/t Au Over 5.00m in Ongoing Oxide Exploration
Figure 1 Bomboré Plan Map Overview VANCOUVER, British Columbia, April 10, 2023 (GLOBE NEWSWIRE) —…
DOCOMO Grants Standard Essential Patent License to Samsung
TOKYO, Apr 10, 2023 – (JCN Newswire) – NTT DOCOMO, INC. announced today that it…
Concerned Shareholders of Cano Health Issue Open Letter Regarding the Urgent Need for Leadership and Strategy Changes at the Company
Group Owning ~36% of Company Outlines Serious Concerns Pertaining to CEO Conduct, Capital Allocation and…